AVP‐825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1526-4610|58|2|229-242

ISSN: 0017-8748

Source: HEADACHE, Vol.58, Iss.2, 2018-02, pp. : 229-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content